Home > Insider Trading > Filing (0001209191-21-014679)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1550395	David Altshuler	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Evp, Global Research And Cso	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2021-02-24	2,416	$217.57	36,617	No	4	F	Direct
Common Stock	Disposition	2021-02-25	646	$211.58	35,971	No	4	S	Direct
Common Stock	Disposition	2021-02-25	1,348	$213.05	34,623	No	4	S	Direct
Common Stock	Disposition	2021-02-25	680	$214.28	33,943	No	4	S	Direct
Common Stock	Disposition	2021-02-25	354	$216.26	33,589	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $211.58 (range $211.34 to $211.91).
Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $213.05 (range $212.76 to $213.68).
Open market sales reported on this line occurred at a weighted average price of $214.28 (range $213.90 to $214.69).
Open market sales reported on this line occurred at a weighted average price of $216.26 (range $215.79 to $216.76).